FindTrial
Sign In

A study to see if adding a specific medicine to an ultrasound-guided nerve block improves pain relief after uterus removal surgery.

Dexmedetomidine as an Adjuvant with 0.2 percent Ropivacaine for Ultrasound Guided Bilateral Quadratus Lumborum Plane Block for Postoperative Analgesia after Total Abdominal Hysterectomy under General Anaesthesia: A Prospective Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113728
Enrollment
50
Registered
2026-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Dexmedetomidine with 0.2 percent Ropivacaine for Ultrasound Guided Bilateral Quadratus Lumborum Plane Block: Patients will receive ultrasound guided bilateral quadratus lumborum plane b

Sponsors

Shri Balaji institute of medical science raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult females aged between 45 to 65 years undergoing elective total abdominal hysterectomy. American Society of Anaesthesiologist (ASA) physical status I or II.

Exclusion criteria

Exclusion criteria: ASA grade III & IV Patients with a known sensitivity to local anaesthetics. Patients with severe cardiovascular, hepatic, or renal disease. Patients undergoing emergency surgeries. Patients with psychiatric disorders affecting the ability to provide informed consent & interfere with evaluation of pain scores. Patient with allergy at the site of block.

Design outcomes

Primary

MeasureTime frame
To compare the duration of postoperative analgesia with 0.2 ropivacaine and dexmedetomidine as adjuvant to 0.2 ropivacaine in Ultrasound guided bilateral quadratus lumborum block in post-operative patients undergoing TAHTimepoint: Assessed for 24 hours after surgery—

Secondary

MeasureTime frame
To evaluate the safety & side-effect profile of adding dexmedetomidine to ropivacaine in Quadratus Lumborum block, including monitoring for hypotension, bradycardia, sedation, & any other potential complications.Timepoint: Post operative nausea bradycardia hypotension vomiting will be observed at 0 2 4 6 8 12 & 24 hours—

Countries

India

Contacts

Public ContactDr Joyita Das

Shri balaji institute of medical science Raipur

reema.tavar@gmail.com9265623026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026